These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27862088)

  • 1. Prognostic dilemmas and genetic counseling for prenatally detected fragile X gene expansions.
    Finucane B; Lincoln S; Bailey L; Martin CL
    Prenat Diagn; 2017 Jan; 37(1):37-42. PubMed ID: 27862088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal carrier testing for fragile X: counseling issues and challenges.
    Musci TJ; Moyer K
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):61-70, Table of Contents. PubMed ID: 20494258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
    Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
    Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of fragile X pre-mutation carriers in the Chinese obstetric population using a robust FMR1 polymerase chain reaction assay: implications for screening and prenatal diagnosis.
    Cheng YK; Lin CS; Kwok YK; Chan YM; Lau TK; Leung TY; Choy KW
    Hong Kong Med J; 2017 Apr; 23(2):110-6. PubMed ID: 28253484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mosaicism for FMR1 gene full mutation and intermediate allele in a female foetus: a postzygotic retraction event.
    Ferreira SI; Pires LM; Ferrão J; Sá J; Serra A; Carreira IM
    Gene; 2013 Sep; 527(1):421-5. PubMed ID: 23792063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of fragile X premutation expansion is lower in carriers detected by general prenatal screening than in carriers from known fragile X families.
    Geva E; Yaron Y; Shomrat R; Ben-Yehuda A; Zabari S; Peretz H; Naiman T; Yeger H; Orr-Urtreger A
    Genet Test; 2000; 4(3):289-92. PubMed ID: 11142761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragile X analysis of 1112 prenatal samples from 1991 to 2010.
    Nolin SL; Glicksman A; Ding X; Ersalesi N; Brown WT; Sherman SL; Dobkin C
    Prenat Diagn; 2011 Oct; 31(10):925-31. PubMed ID: 21717484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FMR1 premutation and reproduction.
    Wittenberger MD; Hagerman RJ; Sherman SL; McConkie-Rosell A; Welt CK; Rebar RW; Corrigan EC; Simpson JL; Nelson LM
    Fertil Steril; 2007 Mar; 87(3):456-65. PubMed ID: 17074338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular testing for Fragile X Syndrome: lessons learned from 119,232 tests performed in a clinical laboratory.
    Strom CM; Crossley B; Redman JB; Buller A; Quan F; Peng M; McGinnis M; Fenwick RG; Sun W
    Genet Med; 2007 Jan; 9(1):46-51. PubMed ID: 17224689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of carrier screening and prenatal diagnosis for FMR1 gene in 819 cases].
    Li J; Du J; Yang Q; Xu J; Li M; Fu H; Li M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Oct; 37(10):1104-1107. PubMed ID: 32924111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragile X mental retardation syndrome: from pathogenesis to diagnostic issues.
    Mandel JL; Biancalana V
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S158-65. PubMed ID: 15135801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic counseling for fragile x syndrome: updated recommendations of the national society of genetic counselors.
    McConkie-Rosell A; Finucane B; Cronister A; Abrams L; Bennett RL; Pettersen BJ
    J Genet Couns; 2005 Aug; 14(4):249-70. PubMed ID: 16047089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic testing in fragile X syndrome].
    Sireteanu A; Rusu C
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(4):968-71. PubMed ID: 17438909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fragile X chromosomes and fragile X syndrome].
    Boonen SE; Grønskov K; Brøndum-Nielsen K
    Ugeskr Laeger; 2006 Oct; 168(43):3727-8. PubMed ID: 17069739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in prenatal screening and counselling for fragile X syndrome.
    Mak AS; Leung KY
    Hong Kong Med J; 2017 Apr; 23(2):108-9. PubMed ID: 28387201
    [No Abstract]   [Full Text] [Related]  

  • 16. A 15-year-long Southern blotting analysis of FMR1 to detect female carriers and for prenatal diagnosis of fragile X syndrome in Taiwan.
    Tzeng CC; Tsai LP; Chang YK; Hung YJ; Chang YY; Su YP; Jiang JJ; Liang HM
    Clin Genet; 2017 Aug; 92(2):217-220. PubMed ID: 28139839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of inclusions positive for polyglycine containing protein, FMRpolyG, indicates that repeat-associated non-AUG translation plays a role in fragile X-associated primary ovarian insufficiency.
    Buijsen RA; Visser JA; Kramer P; Severijnen EA; Gearing M; Charlet-Berguerand N; Sherman SL; Berman RF; Willemsen R; Hukema RK
    Hum Reprod; 2016 Jan; 31(1):158-68. PubMed ID: 26537920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACOG Committee Opinion No. 469: Carrier screening for fragile X syndrome.
    Obstet Gynecol; 2010 Oct; 116(4):1008-1010. PubMed ID: 20859177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the human fragile X mental retardation 1 polymerase chain reaction reagents to amplify the FMR1 gene: testing in a clinical diagnostic laboratory.
    Nahhas FA; Monroe TJ; Prior TW; Botma PI; Fang J; Snyder PJ; Talbott SL; Feldman GL
    Genet Test Mol Biomarkers; 2012 Mar; 16(3):187-92. PubMed ID: 21992462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragile X Syndrome: Introduction.
    Reches A
    Methods Mol Biol; 2019; 1942():3-10. PubMed ID: 30900171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.